Use of 2-octyl-cyanoacrylate Together With a Self-adhering Mesh
NCT ID: NCT01658163
Last Updated: 2013-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2009-06-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of PrineoTM (Dermabond Protape) Skin Adhesive for Wound Closure Following Abdominoplasty
NCT01544556
Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section
NCT06760026
Subcuticular Suture for Cesarean Skin Incision Closure
NCT02459093
Study of DERMABOND ProPen in Closure of Colectomy Wounds
NCT00978133
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen
NCT05568238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* known HIV-positive or other immunocompromised status
* known or suspected allergy or sensitivity to cyanoacrylate, formaldehyde, tapes or adhesives
* personal or family history of keloid or hypertrophic scar formation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daryousch Parvizi, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Prineo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.